Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
DDX17 is an essential mediator of sterile NLRC4 inflammasome activation by retrotransposon RNAs.
Wang SB, Narendran S, Hirahara S, Varshney A, Pereira F, Apicella I, Ambati M, Ambati VL, Yerramothu P, Ambati K, Nagasaka Y, Argyle D, Huang P, Baker KL, Marion KM, Gupta K, Liu B, Hinton DR, Canna SW, Sallam T, Sadda SR, Kerur N, Gelfand BD, Ambati J. Wang SB, et al. Among authors: baker kl. Sci Immunol. 2021 Dec 3;6(66):eabi4493. doi: 10.1126/sciimmunol.abi4493. Epub 2021 Dec 3. Sci Immunol. 2021. PMID: 34860583 Free PMC article.
Nucleoside reverse transcriptase inhibitors and Kamuvudines inhibit amyloid-β induced retinal pigmented epithelium degeneration.
Narendran S, Pereira F, Yerramothu P, Apicella I, Wang SB, Ambati K, Hirahara S, Kim Y, Ambati M, Ambati VL, Huang P, Varshney A, Nagasaka Y, Fukuda S, Baker KL, Marion KM, Deussing JM, Sadda SR, Gelfand BD, Ambati J. Narendran S, et al. Among authors: baker kl. Signal Transduct Target Ther. 2021 Apr 14;6(1):149. doi: 10.1038/s41392-021-00537-z. Signal Transduct Target Ther. 2021. PMID: 33850097 Free PMC article.
Alu complementary DNA is enriched in atrophic macular degeneration and triggers retinal pigmented epithelium toxicity via cytosolic innate immunity.
Fukuda S, Narendran S, Varshney A, Nagasaka Y, Wang SB, Ambati K, Apicella I, Pereira F, Fowler BJ, Yasuma T, Hirahara S, Yasuma R, Huang P, Yerramothu P, Makin RD, Wang M, Baker KL, Marion KM, Huang X, Baghdasaryan E, Ambati M, Ambati VL, Banerjee D, Bonilha VL, Tolstonog GV, Held U, Ogura Y, Terasaki H, Oshika T, Bhattarai D, Kim KB, Feldman SH, Aguirre JI, Hinton DR, Kerur N, Sadda SR, Schumann GG, Gelfand BD, Ambati J. Fukuda S, et al. Among authors: baker kl. Sci Adv. 2021 Oct;7(40):eabj3658. doi: 10.1126/sciadv.abj3658. Epub 2021 Sep 29. Sci Adv. 2021. PMID: 34586848 Free PMC article.
Identification of fluoxetine as a direct NLRP3 inhibitor to treat atrophic macular degeneration.
Ambati M, Apicella I, Wang SB, Narendran S, Leung H, Pereira F, Nagasaka Y, Huang P, Varshney A, Baker KL, Marion KM, Shadmehr M, Stains CI, Werner BC, Sadda SR, Taylor EW, Sutton SS, Magagnoli J, Gelfand BD. Ambati M, et al. Among authors: baker kl. Proc Natl Acad Sci U S A. 2021 Oct 12;118(41):e2102975118. doi: 10.1073/pnas.2102975118. Proc Natl Acad Sci U S A. 2021. PMID: 34620711 Free PMC article.
Cytoplasmic synthesis of endogenous Alu complementary DNA via reverse transcription and implications in age-related macular degeneration.
Fukuda S, Varshney A, Fowler BJ, Wang SB, Narendran S, Ambati K, Yasuma T, Magagnoli J, Leung H, Hirahara S, Nagasaka Y, Yasuma R, Apicella I, Pereira F, Makin RD, Magner E, Liu X, Sun J, Wang M, Baker K, Marion KM, Huang X, Baghdasaryan E, Ambati M, Ambati VL, Pandey A, Pandya L, Cummings T, Banerjee D, Huang P, Yerramothu P, Tolstonog GV, Held U, Erwin JA, Paquola ACM, Herdy JR, Ogura Y, Terasaki H, Oshika T, Darwish S, Singh RK, Mozaffari S, Bhattarai D, Kim KB, Hardin JW, Bennett CL, Hinton DR, Hanson TE, Röver C, Parang K, Kerur N, Liu J, Werner BC, Sutton SS, Sadda SR, Schumann GG, Gelfand BD, Gage FH, Ambati J. Fukuda S, et al. Proc Natl Acad Sci U S A. 2021 Feb 9;118(6):e2022751118. doi: 10.1073/pnas.2022751118. Proc Natl Acad Sci U S A. 2021. PMID: 33526699 Free PMC article.
A Clinical Metabolite of Azidothymidine Inhibits Experimental Choroidal Neovascularization and Retinal Pigmented Epithelium Degeneration.
Narendran S, Pereira F, Yerramothu P, Apicella I, Wang SB, Varshney A, Baker KL, Marion KM, Ambati M, Ambati VL, Ambati K, Sadda SR, Gelfand BD, Ambati J. Narendran S, et al. Among authors: baker kl. Invest Ophthalmol Vis Sci. 2020 Aug 3;61(10):4. doi: 10.1167/iovs.61.10.4. Invest Ophthalmol Vis Sci. 2020. PMID: 32749462 Free PMC article.
The impact of low-mode symmetry on inertial fusion energy output in the burning plasma state.
Ralph JE, Ross JS, Zylstra AB, Kritcher AL, Robey HF, Young CV, Hurricane OA, Pak A, Callahan DA, Baker KL, Casey DT, Döppner T, Divol L, Hohenberger M, Pape SL, Patel PK, Tommasini R, Ali SJ, Amendt PA, Atherton LJ, Bachmann B, Bailey D, Benedetti LR, Berzak Hopkins L, Betti R, Bhandarkar SD, Biener J, Bionta RM, Birge NW, Bond EJ, Bradley DK, Braun T, Briggs TM, Bruhn MW, Celliers PM, Chang B, Chapman T, Chen H, Choate C, Christopherson AR, Clark DS, Crippen JW, Dewald EL, Dittrich TR, Edwards MJ, Farmer WA, Field JE, Fittinghoff D, Frenje J, Gaffney J, Gatu Johnson M, Glenzer SH, Grim GP, Haan S, Hahn KD, Hall GN, Hammel BA, Harte J, Hartouni E, Heebner JE, Hernandez VJ, Herrmann HW, Herrmann MC, Hinkel DE, Ho DD, Holder JP, Hsing WW, Huang H, Humbird KD, Izumi N, Jarrott LC, Jeet J, Jones O, Kerbel GD, Kerr SM, Khan SF, Kilkenny J, Kim Y, Geppert-Kleinrath H, Geppert-Kleinrath V, Kong C, Koning JM, Kroll JJ, Kruse MKG, Kustowski B, Landen OL, Langer S, Larson D, Lemos NC, Lindl JD, Ma T, MacDonald MJ, MacGowan BJ, Mackinnon AJ, MacLaren SA, MacPhee AG, Marinak MM, Mariscal DA, Marley EV, Masse L, Meaney KD, Meezan NB, Michel PA, Millot M, Milovich JL, Moody JD, Moore AS… See abstract for full author list ➔ Ralph JE, et al. Among authors: baker kl. Nat Commun. 2024 Apr 6;15(1):2975. doi: 10.1038/s41467-024-47302-8. Nat Commun. 2024. PMID: 38582938 Free PMC article.
Observations and properties of the first laboratory fusion experiment to exceed a target gain of unity.
Pak A, Zylstra AB, Baker KL, Casey DT, Dewald E, Divol L, Hohenberger M, Moore AS, Ralph JE, Schlossberg DJ, Tommasini R, Aybar N, Bachmann B, Bionta RM, Fittinghoff D, Gatu Johnson M, Geppert Kleinrath H, Geppert Kleinrath V, Hahn KD, Rubery MS, Landen OL, Moody JD, Aghaian L, Allen A, Baxamusa SH, Bhandarkar SD, Biener J, Birge NW, Braun T, Briggs TM, Choate C, Clark DS, Crippen JW, Danly C, Döppner T, Durocher M, Erickson M, Fehrenbach T, Freeman M, Havre M, Hayes S, Hilsabeck T, Holder JP, Humbird KD, Hurricane OA, Izumi N, Kerr SM, Khan SF, Kim YH, Kong C, Jeet J, Kozioziemski B, Kritcher AL, Lamb KM, Lemos NC, MacGowan BJ, Mackinnon AJ, MacPhee AG, Marley EV, Meaney K, Millot M, Di Nicola JG, Nikroo A, Nora R, Ratledge M, Ross JS, Shin SJ, Smalyuk VA, Stadermann M, Stoupin S, Suratwala T, Trosseille C, Van Wonterghem B, Weber CR, Wild C, Wilde C, Wooddy PT, Woodworth BN, Young CV. Pak A, et al. Among authors: baker kl. Phys Rev E. 2024 Feb;109(2-2):025203. doi: 10.1103/PhysRevE.109.025203. Phys Rev E. 2024. PMID: 38491694
Design of the first fusion experiment to achieve target energy gain G>1.
Kritcher AL, Zylstra AB, Weber CR, Hurricane OA, Callahan DA, Clark DS, Divol L, Hinkel DE, Humbird K, Jones O, Lindl JD, Maclaren S, Strozzi DJ, Young CV, Allen A, Bachmann B, Baker KL, Braun T, Brunton G, Casey DT, Chapman T, Choate C, Dewald E, Di Nicola JG, Edwards MJ, Haan S, Fehrenbach T, Hohenberger M, Kur E, Kustowski B, Kong C, Landen OL, Larson D, MacGowan BJ, Marinak M, Millot M, Nikroo A, Nora R, Pak A, Patel PK, Ralph JE, Ratledge M, Rubery MS, Schlossberg DJ, Sepke SM, Stadermann M, Suratwala TI, Tommasini R, Town R, Woodworth B, Van Wonterghem B, Wild C. Kritcher AL, et al. Among authors: baker kl. Phys Rev E. 2024 Feb;109(2-2):025204. doi: 10.1103/PhysRevE.109.025204. Phys Rev E. 2024. PMID: 38491565
96 results